Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis.
Saved in:
| Title: | Targeting the SphK1/S1P/PFKFB3 axis suppresses hepatocellular carcinoma progression by disrupting glycolytic energy supply that drives tumor angiogenesis. |
|---|---|
| Authors: | Liu, Xin Tracy1 (AUTHOR), Huang, Yu1 (AUTHOR), Liu, Da1 (AUTHOR), Jiang, Yingxin Celia1 (AUTHOR), Zhao, Min2 (AUTHOR), Chung, Long Hoa1 (AUTHOR), Han, Xingxing Daisy1 (AUTHOR), Zhao, Yinan3 (AUTHOR), Chen, Jinbiao1 (AUTHOR), Coleman, Paul1 (AUTHOR), Ting, Ka Ka1 (AUTHOR), Tran, Collin4 (AUTHOR), Su, Yingying5 (AUTHOR), Dennis, Claude Vincent6 (AUTHOR), Bhatnagar, Atul7 (AUTHOR), Liu, Ken6 (AUTHOR), Don, Anthony Simon4 (AUTHOR), Vadas, Mathew Alexander1 (AUTHOR), Gorrell, Mark Douglas1,6 (AUTHOR), Zhang, Shubiao3 (AUTHOR) |
| Source: | Journal of Translational Medicine. 1/10/2024, Vol. 22 Issue 1, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
